Currently Viewing:
Newsroom
Currently Reading
Researchers Identify and Silence Long Noncoding RNA Responsible for HIV Replication
September 27, 2019 – Jaime Rosenberg
This Week in Managed Care: September 20, 2019
September 20, 2019
Initiating Treatment in EDs Could Be Critical for Containing Spread of HIV
September 19, 2019 – Jaime Rosenberg
HIV Associated With Significantly Increased Risk of Atrial Fibrillation
September 16, 2019 – Jaime Rosenberg
How Many People Actually Get Screened for HIV?
September 14, 2019 – Jaime Rosenberg
People Living With HIV Face Significant Burden of Kidney Disease, Researchers Say
September 11, 2019 – Jaime Rosenberg
While Adherence to ART Regimens Has Improved Among People With HIV, Rates Remain Suboptimal
September 06, 2019 – Jaime Rosenberg
EMERALD Subgroup Analyses Demonstrate Safety, Efficacy of Switching Certain Patients With HIV to Symtuza
September 04, 2019 – Jaime Rosenberg
Top 5 AJMC® Articles of August 2019
August 31, 2019

Researchers Identify and Silence Long Noncoding RNA Responsible for HIV Replication

Jaime Rosenberg
According to the researchers, the long noncoding RNA, when turned off or deleted, eliminates dormant HIV reservoirs that persist even when patients adhere here to their antiretroviral therapy regimen and are virally suppressed.
Researchers from the University of California San Diego School of Medicine say they have identified a principal cellular player controlling HIV reproduction in immune cells by using genetic sequencing.

According to the researchers, the long noncoding RNA, when turned off or deleted, eliminates dormant HIV reservoirs that persist even when patients adhere here to their antiretroviral therapy (ART) regimen and are virally suppressed.

“This is one of the key switches that the HIV field has been searching for three decades to find,” said Tariq Rana, PhD, professor of pediatrics and genetics at the university, in a statement. He added, “By genetically modifying a long noncoding RNA, we prevent HIV recurrence in T cells and microglia upon cessation of antiretroviral treatment, suggesting that we have a potential therapeutic target to eradicate HIV and AIDS.”

Rana and colleagues used a combination of genomic, biochemical, and cellular approaches, discovering that silencing the single long noncoding RNA that they called HIV-1 enhanced lncRNA (HEAL), or removing it by using CRISPR, prevented HIV from recurring when ART was stopped. Typically, when ART is stopped, the virus awakens and a patient becomes unsuppressed.

“Our results suggest that HEAL plays a critical role in HIV pathogenesis,” said Rana.

HEAL, which is elevated in people with HIV, is conserved only in chimpanzees and rhesus monkeys, “suggesting that it is a recently emerged gene.”

According to the researchers, the gene regulates HIV replication in immune cells, such as macrophages, microglia, and T cells, by forming an RNA-protein complex with RNA-binding protein FUS, which is specifically enriched at the promoter of the cyclin-dependent kinase 2 gene, or CDK2, thus allowing the gene to regulate CDK2 expression in T cells.

This is the first genome-wide expression analysis of long noncoding RNA in HIV-infected macrophages—the immune cells that promote tissue inflammation, stimulate the immune system, and rid the body of foreign agents, they said.

They added that more research is needed to explain the precise signaling mechanism that produces HEAL expression once a patient is infected by HIV, as well as how its expression is restricted during viral latency.

Reference:

Chao T, Zhang Q, Li Z, et al. The long noncoding RNA HEAL regulates HIV-1 replication through epigenetic regulation of the HIV-1 promoter [published online September 24, 2019]. mBio. doi: 10.1128/mBio.02016-19.

 
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up